The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation.
Soshi KadenaNobuyoshi KosakaKosuke IwataniHirotaka SuzukiYu ImaiKojiro TashiroShunsuke TsuzukiMariko HondaYusuke KoikeTatsuya ShimomuraManabu AokiShun SatoHiroyuki TakahashiKenta MikiTakahiro KimuraPublished in: International journal of clinical oncology (2023)
The clinical T stage and GG status were significantly prognostic of oncological outcomes in patients with locally advanced PCa. In patients of GG ≤ 4 PCa, HDR-BT was effective even in patients with cT3b or cT4 PCa. However, in patients with GG5 PCa, careful monitoring is essential, particularly of patients with cT3b or cT4 PCa.
Keyphrases
- locally advanced
- high dose
- image quality
- dual energy
- rectal cancer
- contrast enhanced
- computed tomography
- prostate cancer
- neoadjuvant chemotherapy
- squamous cell carcinoma
- radiation therapy
- positron emission tomography
- low dose
- radical prostatectomy
- ejection fraction
- phase ii study
- magnetic resonance
- clinical trial
- prognostic factors
- adipose tissue
- double blind